Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...

The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing an insulin pump to manage blood sugar levels. Instead, their new cell-based ...

Learn why GLP-1 use isn’t included in how experts define type 2 diabetes remission despite the drugs’ ability to help manage blood sugar and reduce a person’s A1C.

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for creating insulin-producing cells from human stem cells. The results, ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

The “4S Pathway” offers strategies for realigning treatment goals and approaches for older adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) who are struggling with self-management. “This is ...

Share on Pinterest A new study suggests that a large percentage of people with diabetes are unaware they have the disease. Justin Paget/Getty Images Researchers estimate that around 44% of people in ...

Please provide your email address to receive an email when new articles are posted on . Just 55.8% of people living with diabetes globally had a diagnosis in 2023. Only 21.2% of all people with ...

SP16 is an investigational intravenous therapy designed to treat chemotherapy-induced pain and peripheral neuropathy, also ...